Foru Holdings

Foru Holdings, Inc. is a health and wellness company, primarily known for its subsidiary Foru International, which pioneered DNA-customized nutritional and skincare products. The company's business model focused on nutrigenomics, utilizing proprietary genetic assessments of specific single nucleotide polymorphisms (SNPs) to provide personalized supplements (SNP-Caps) and serums (SNP-Serum) tailored to an individual's genetic profile. Originally established as GeneWize Life Sciences, the company leveraged technologies developed by GeneLink Biosciences before transitioning through several corporate owners, including Capsalus Corp. Despite early leadership in the consumer genetics sector, the company faced significant regulatory scrutiny, notably a 2014 settlement with the Federal Trade Commission regarding deceptive health claims. Currently, the company exists primarily as a public shell company with limited active operations.